Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Funding for clinical trials.

C L Meinert

    Controlled Clinical Trials
    |September 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    This review examines National Institutes of Health (NIH) funding for clinical trials, analyzing trial costs and design. It identifies factors contributing to the overall expense of conducting these vital research studies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Insurance status and mortality among patients with AIDS.

    HIV medicine·2017
    Same author

    Factors affecting attrition in a longitudinal study of patients with AIDS.

    AIDS care·2006
    Same author

    Double-masked randomized trial comparing alternate combinations of intraoperative anesthesia and postoperative analgesia in abdominal aortic surgery.

    Anesthesiology·2001
    Same author

    Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2001
    Same author

    Estimation of gender bias in clinical trials.

    Statistics in medicine·2001
    Same author

    Enrollment of women in cardiovascular clinical trials.

    The New England journal of medicine·2001
    Same journal

    On the generation and ownership of alpha in medical studies.

    Controlled clinical trials·2004
    Same journal

    An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

    Controlled clinical trials·2004
    Same journal

    Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

    Controlled clinical trials·2004
    Same journal

    Statistical comparison of random allocation methods in cancer clinical trials.

    Controlled clinical trials·2004
    Same journal

    Analyzing bronchodilation with emphasis on disease type, age and sex.

    Controlled clinical trials·2004
    Same journal

    Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

    Controlled clinical trials·2004
    See all related articles

    Area of Science:

    • Clinical research funding
    • Health services research
    • Biomedical research administration

    Background:

    • Clinical trials are essential for medical advancement but require substantial funding.
    • The National Institutes of Health (NIH) is a primary funder of clinical trials.
    • Understanding funding sources and cost drivers is crucial for efficient research.

    Purpose of the Study:

    • To review available funding sources for clinical trials.
    • To specifically analyze funding, cost, and design characteristics of NIH-funded trials.
    • To discuss factors influencing the cost of clinical trials.

    Main Methods:

    • Review of literature on clinical trial funding.
    • Analysis of data from the NIH Inventory of Clinical Trials.

    Related Experiment Videos

  • Summarization of cost and design features of NIH-supported studies.

    • Main Results:

    • NIH is a significant funder of clinical trials.
    • Key design characteristics and associated costs of NIH trials are summarized.
    • Several factors contributing to trial costs are identified.

    Conclusions:

    • NIH funding plays a critical role in clinical trial research.
    • Cost analysis and understanding design impacts are vital for optimizing trial budgets.
    • Further investigation into cost-saving strategies for clinical trials is warranted.